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Myotonic dystrophies (DMs) are autosomal dominant, multisystemic diseases with 
a core pattern of clinical presentation including myotonia, muscular dystrophy, cardiac 
conduction defects, posterior iridescent cataracts, and endocrine disorders. Myotonic 
dystrophies (DMs) encompass at least 2 forms: myotonic dystrophy type 1 and 2. Myot-
onic dystrophy (DM) is a complex multisystemic disorder linked to two different genetic 
loci. Myotonic dystrophy type 1 (DM1) is caused by an expansion of a CTG repeat lo-
cated in the 3’ untranslated region (UTR) of DMPK (myotonic dystrophy protein kinase) 
on chromosome 19q13.3. Myotonic dystrophy type 2 (DM2) is caused by an unstable 
CCTG repeat in intron 1 of ZNF9 (zinc finger protein 9) on chromosome 3q21. Therefore, 
both DM1 and DM2 are caused by a repeat expansion in a region transcribed into RNA 
but not translated into protein. The elevation of cyclin D3 in differentiated myotubes 
has been previously published. The lack of elevation of cyclin D3 in DM1 differentiat-
ing cells seems to be a critical event leading to impaired myoblast fusion. Cyclin D3 is 
a specific target for PI-PLCβ1 signaling. In particular, investigations on skeletal muscle 
development strengthen the contention that nuclear PLCβ1 signaling is required for the 
activation of the cyclin D3 promoter in C2C12 cell. Here we show that PLCβ1 expression 
is down-regulated during differentiation of DM1 and DM2 cells. Our evidence suggests 
that the overexpression of PLCβ1 in these cells is directly responsible for the overexpres-
sion of cyclin D3 and myogenin leading to an increased fusion of DM cells. Thus, nor-
malization of cyclin D3 evoked by ectopic expression of PLCβ1 might be a therapeutic 
approach to correct differentiation of skeletal muscle in DM patients.
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